Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2005
09/21/2005EP1200115B1 Multi-dose erythropoietin formulations
09/21/2005EP1192256B1 Global regulators of bacterial pathogenic genes; bacterial autoinducer inactivation protein, as targets for engineering disease resistance
09/21/2005EP1191037B1 Means of stabilizing hemoglobins
09/21/2005EP1094830B1 USE OF COMPOSITION COMPRISING AT LEAST ONE SUBSTANCE WITHIN THE GROUP GnRH-ANALOGUES FOR TREATMENT OF OBSESSIVE-COMPULSIVE DISORDER (OCD)
09/21/2005EP1094081B1 Fused protein with direct bond of il-6-receptor to il-6
09/21/2005EP1061805B1 Regulation of endogenous gene expression in cells using zinc finger proteins
09/21/2005EP1027371B1 Process for the production of highly viral safe thrombin for forming fibrin glue from a pool of human plasma
09/21/2005EP1002065B1 Nanocrystalline formulations of human immunodeficiency virus (hiv) protease inhibitors using cellulosic surface stabilizers and methods of making such formulations
09/21/2005EP0996459B1 Use of exendins and agonists thereof for the reduction of food intake
09/21/2005EP0846171B1 Chromosome 1 gene and gene products related to alzheimer's disease
09/21/2005EP0793721B1 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof
09/21/2005EP0792364B1 Lgmd gene coding for a calcium dependent protease
09/21/2005EP0776337B1 Growth differentiation factor-11
09/21/2005EP0764205B1 Chondroitin lyase enzymes
09/21/2005CN1672046A Method for identifying substances
09/21/2005CN1671863A Central airway administration for systemic delivery of therapeutics
09/21/2005CN1671844A Antigenic neisserial peptides
09/21/2005CN1671835A A method for the establishment of a pluripotent human blastocyst-derived stem cell line
09/21/2005CN1671831A 消毒组合物 Disinfecting composition
09/21/2005CN1671742A Use of HMGB1 in the treatment of tissue damage and/or to promote tissue repair
09/21/2005CN1671737A Export and modification of (poly)peptides in the lantibiotic way
09/21/2005CN1671736A Pegylated T20 polypeptide
09/21/2005CN1671735A Pegylated T1249 polypeptide
09/21/2005CN1671734A CFTR modifier genes and expressed polypeptides useful in treating cystic fibrosis and methods and products for detecting and/or identifying same
09/21/2005CN1671733A Compositions and methods for WT1 specific immunotherapy
09/21/2005CN1671732A Process for purifying glycopeptide phospohonate derivatives
09/21/2005CN1671730A Oligonucleotide-containing pharmacological compositions and their use
09/21/2005CN1671729A Control sequences of the human Corin gene
09/21/2005CN1671425A ACE2 activation for treatment of heart, lung and kidney disease and hypertension
09/21/2005CN1671424A Decoy composition for treating and preventing inflammatory disease
09/21/2005CN1671423A Novel chimeric CD154
09/21/2005CN1671420A Pegylated factor VII glycoforms
09/21/2005CN1671418A Oral administration of calcitonin
09/21/2005CN1671415A Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26
09/21/2005CN1671411A Enzymatic treatment of retinitis pigmentosa and relevant pharmaceutical composition in form of a kit
09/21/2005CN1671410A Stabilised solid compositions of factor VII polypeptides
09/21/2005CN1671409A Topical drug delivery using phosphatidylcholine
09/21/2005CN1671408A Treatment of hepatitis C in the asian population with subcutaneous interferonbeta
09/21/2005CN1671407A Compositions and methods for treating diabetes
09/21/2005CN1671395A Process for preparing water soluble phosphonooxymethyl derivatives of alcohol and phenol
09/21/2005CN1671362A Biodegradable block copolymeric compositions for drug delivery
09/21/2005CN1670206A Protease subunit C7-I of clonorchis sinensis, its coding nucleic acid and application
09/21/2005CN1670205A Protease subunit C3 of clonorchis sinensis, its coding nucleic acid and application
09/21/2005CN1670204A Autolytic enzyme of streptococcus pneumoniae, its coding nucleic acid and application
09/21/2005CN1670202A Microsome GST-1 of clonorchis sinensis, its coding acid and application
09/21/2005CN1670201A Fumaric reductase Ip subunit of liver fluke, its coding acid and application
09/21/2005CN1670200A Lactate dehydrogenase of clonorchis sinensis, its coding nucleic acid and application
09/21/2005CN1670199A I type aldehyde dehydrogenase of clonorchis sinensis, its coding nucleic acid and application
09/21/2005CN1670198A Thermostable type cytoplasm malic dehydrogenase of clonorchis sinensis, its coding nucleic acid and application
09/21/2005CN1670197A Arginase of Japanese blood fluke, its coding nucleic acid and application
09/21/2005CN1670196A Adenylate kinase 3 of clonorchis sinensis, its coding nucleic acid and application
09/21/2005CN1670195A Propionyl-CoA carboxylase of clonorchis sinensis, its coding nucleic acid and application thereof
09/21/2005CN1670194A Calcineurin of clonorchis sinensis, its coding nucleic acid and application
09/21/2005CN1670032A Human telomerase active inhibitor protein and use thereof
09/21/2005CN1669583A 人参胶原蛋白 Ginseng Collagen
09/21/2005CN1669582A 胶原钙 Collagen calcium
09/21/2005CN1669581A Medicinal composition containing dendritic cell-specific intercellular adhesion factor-3 snatch nonconformity element, cleaning supplies and uses thereof
09/21/2005CN1219882C Method and combination for treating tumors based on ERBB-3
09/21/2005CN1219796C Application of N-end amino acid of interferon-tau polypeptide
09/21/2005CN1219795C Renaturation process for preparing human recombinant nerve growth factor
09/21/2005CN1219794C Platelet glucoprotein receptor inhibitor, medicinal composition containing same and use thereof
09/21/2005CN1219548C Join of C peptide and insulin for treating diabetes complication and C peptide-specific antibody
09/20/2005US6946548 Granulocyte colony stimulating factor ("G-CSF") analog polypeptide compositions, related nucleic acids, expression constructs, host cells, and processes for recombinant production of the present G-CSF analogs.
09/20/2005US6946544 XAF genes and polypeptides: methods and reagents for modulating apoptosis
09/20/2005US6946543 Truncated EGF receptor
09/20/2005US6946492 Use of C2-substituted indan-1-one systems for preparing medicaments for the treatment of obesity
09/20/2005US6946490 Medicine comprises Echinacea phytochemicals and benzalkonium chloride in a sterile water solution; for therapy
09/20/2005US6946480 Glutaminyl based DPIV inhibitors
09/20/2005US6946465 Immunosuppressive effects of pteridine derivatives
09/20/2005US6946459 Crystalline forms of 1s-[1alpha(2s*,3r*), 9alpha]6, 10-dioxo-n-(2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9[[(1-isoquinolyl) carbonyl]amino]octahydro-6h-piridazino[1,2-a][1,2]diazepin-1-carboxamide
09/20/2005US6946447 Inhibiting expression of MDM2 in a mammal by administering an anti-MDM2 antisense oligonucleotide; synergistically activating a tumor suppressor
09/20/2005US6946445 peptide antagonists of CXC chemokine receptor 4, CXCR4; cancer and autoimmune diseases; protein that comprises an N-terminal sequence of KGVSLSYR (SEQ ID NO: 3); stromal cell derived factor one (SDF-1 ligand
09/20/2005US6946444 Modify the activity of the lipolysis stimulated receptor and can be used to influence the partitioning of dietary lipids between the liver and peripheral tissues; treating obesity-related insulin resistance
09/20/2005US6946442 Method of hastening cervical ripening
09/20/2005US6946441 Inhibition of histone deacetylase as a treatment for cardiac hypertrophy
09/20/2005US6946440 Composition for stabilizing corneal tissue during or after orthokeratology lens wear
09/20/2005US6946439 Angiogenesis inhibitors; antitumor agents
09/20/2005US6946438 focal cerebral ischemic infarction; plasmin, mini-plasmin (lacking the first four kringles), and micro-plasmin (lacking all five kringles)
09/20/2005US6946296 Methods and compositions for polypeptide engineering
09/20/2005US6946289 Single-stranded polynucleotides that code for human melanoma antigen(MAGE) and human leukocyte antigens, used in gene therapy and medical diagnosis; immunology
09/20/2005US6946279 Thrombin derivatives and process for producing the same, anhydrothrombin derivatives and process for producing the same, platelet agglutination-inducing compositions, method of inducing platelet agglutination, clinical test reagents, clinical test method, thrombosis inhibitors, adsorbent and process for producing the same
09/20/2005US6946276 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
09/20/2005US6946274 13245, a novel human myotonic dystrophy type protein kinase and uses therefor
09/20/2005US6946265 Genetic engineered polypeptides having replacements in the amino acid sequences, used as for prophylaxis of growth disorders such as turner's syndrome, muscular dystrophy, congestive heart failure, bone and metabolic disorders; stability
09/20/2005US6946264 DNA codes for polypeptides having amino acid sequences used as metalloenzyme inhibitors, for prophylaxis of autoimmune diseases or as wound healing agents
09/20/2005US6946260 Allergen/inflammatory testing and diagnosis
09/20/2005US6946256 Cell regulatory genes, encoded products, and uses related thereto
09/20/2005US6946255 Monoclonal antibody reacting specifically reacting with Fas ligand and production process thereof
09/20/2005US6946253 Azodicarbonamide ejects zinc bound to protein; solid phase synthesis; nuclear magnetic resonance
09/20/2005US6946246 Gene expression by culturing cells and contacting with transcription factors comprising single-stranded oligonucleotides or complementary sequences; genetic engineering; gene therapy
09/20/2005US6946140 Methods and compositions for enhancing fibroblast migration
09/20/2005US6946135 Prevention and treatment of amyloidogenic disease
09/20/2005US6946133 Prostate specific antigen oligo-epitope peptide
09/20/2005US6946132 Pure dnaJp1 peptide in a carrier; dnaJ is a heat shock protein; also immunoassay for identifying persons who are predisposed to develop rheumatoid arthritis
09/20/2005US6946131 Comprises heparan sulfate proteoglyeans; antiproliferative agents
09/20/2005US6946130 interleukins (IL-5); for treating conditions associated with excess eosinophil production (such as chronic eosinophilic pneumonia, allergic bronchopulmonary aspergillosis, coeliac disease and/or gastroenteritis)
09/20/2005US6946129 Recombinant anti-CD40 antibody and uses thereof
09/20/2005US6946128 Protease conjugates having sterically protected epitope regions
09/20/2005US6946125 Methods of treating West Nile virus infection
09/20/2005CA2285119C Retroviral protease inhibiting compounds
1 ... 1377 1378 1379 1380 1381 1382 1383 1384 1385 1386 1387 1388 1389 1390 1391 1392 1393 1394 1395 1396 1397 ... 3163